Xeris Biopharma Holdings, Inc. (XERS) quarterly balance sheet — complete assets, liabilities & equity history
| Total Current Assets | 251.68M | 240.31M | 224.02M | 185.58M | 163.49M | 167.66M | 162.8M | 170.34M | 173.28M | 156.26M | 158.05M | 155.74M |
| Cash & Short-Term Investments | 111.75M | 111.04M | 91.6M | 59.28M | 58.44M | 71.62M | 69.4M | 77.57M | 87.35M | 72.45M | 65.97M | 80.67M |
| Cash Only | 111.75M | 111.04M | 91.6M | 59.28M | 58.44M | 71.62M | 59.23M | 57.6M | 62.69M | 67.45M | 46.14M | 46.17M |
| Short-Term Investments | 0 | 0 | 0 | 0 | 0 | 0 | 10.17M | 19.96M | 24.66M | 5M | 19.83M | 34.5M |
| Accounts Receivable | 56.3M | 51.05M | 53.75M | 53.05M | 46.33M | 40.41M | 41.14M | 42.44M | 37.41M | 39.2M | 45.97M | 30.23M |
| Days Sales Outstanding | 58.11 | 56.18 | 66.05 | 63.21 | 64.93 | 62.42 | 70.84 | 75.59 | 85.78 | 88.25 | 72.53 | 73.13 |
| Inventory | 74.23M | 68.67M | 67.46M | 67.28M | 52.69M | 48.17M | 45.12M | 42.98M | 40.88M | 38.84M | 38.14M | 36.54M |
| Days Inventory Outstanding | 484.1 | 328.23 | 563.68 | 373.65 | 520.04 | 452.79 | 298.13 | 363.37 | 607.45 | 344.43 | 418.89 | 394.94 |
| Other Current Assets | 9.4M | 9.55M | 11.21M | 5.96M | 6.03M | 7.45M | 7.14M | 7.36M | 7.64M | 5.78M | 7.97M | 8.31M |
| Total Non-Current Assets | 140.33M | 143.21M | 146.17M | 149.11M | 151.96M | 155.4M | 158.31M | 161.39M | 163.34M | 166.34M | 169.73M | 173.04M |
| Property, Plant & Equipment | 26.98M | 27.06M | 27.21M | 27.69M | 27.79M | 28.21M | 28.37M | 28.7M | 28.81M | 29.18M | 29.59M | 30.18M |
| Fixed Asset Turnover | 3.08x | 3.16x | 2.71x | 2.58x | 2.15x | 2.12x | 1.90x | 1.67x | 1.40x | 1.51x | 1.62x | 1.87x |
| Goodwill | 22.86M | 22.86M | 22.86M | 22.86M | 22.86M | 22.86M | 22.86M | 22.86M | 22.86M | 22.86M | 22.86M | 22.86M |
| Intangible Assets | 85.37M | 88.08M | 90.79M | 93.5M | 96.21M | 98.92M | 101.63M | 104.34M | 107.05M | 109.76M | 112.47M | 115.19M |
| Long-Term Investments | 0 | 0 | 0 | 0 | 4.12M | 4.12M | 0 | 4.22M | 0 | 0 | 0 | 0 |
| Other Non-Current Assets | 5.12M | 5.22M | 5.32M | 5.06M | 975K | 1.28M | 5.44M | 1.27M | 4.61M | 4.54M | 4.81M | 4.81M |
| Total Assets | 392.01M | 383.53M | 370.19M | 334.69M | 315.45M | 323.06M | 321.1M | 331.73M | 336.62M | 322.6M | 327.78M | 328.78M |
| Asset Turnover | 0.21x | 0.23x | 0.21x | 0.22x | 0.19x | 0.19x | 0.17x | 0.14x | 0.12x | 0.14x | 0.15x | 0.12x |
| Asset Growth % | 24.27% | 18.72% | 15.29% | 0.89% | -6.29% | 0.14% | -2.04% | 0.9% | 4.75% | -6.36% | 8.17% | 3.19% |
| Total Current Liabilities | 118.59M | 109.57M | 116.2M | 95.17M | 95.07M | 100.44M | 91.01M | 75.49M | 73.08M | 95.19M | 87.04M | 79.68M |
| Accounts Payable | 11.47M | 3.08M | 6.53M | 9.46M | 6.35M | 2.29M | 7.45M | 5.8M | 7.09M | 11.56M | 12.08M | 11.62M |
| Days Payables Outstanding | 49.26 | 23.15 | 66.89 | 49.25 | 44.56 | 47.28 | 44.84 | 55.87 | 142.18 | 105.79 | 132.93 | 142.16 |
| Short-Term Debt | 6.27M | 6.23M | 6.19M | 0 | 11.96M | 15.1M | 15.06M | 0 | 0 | 0 | 0 | 0 |
| Deferred Revenue (Current) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Current Liabilities | 100.86M | 100.27M | 103.48M | 36.46M | 32.38M | 39.75M | 34.83M | 51.56M | 26.78M | 51.43M | 43.69M | 40.64M |
| Current Ratio | 2.12x | 2.19x | 1.93x | 1.95x | 1.72x | 1.67x | 1.79x | 2.26x | 2.37x | 1.64x | 1.82x | 1.95x |
| Quick Ratio | 1.50x | 1.57x | 1.35x | 1.24x | 1.17x | 1.19x | 1.29x | 1.69x | 1.81x | 1.23x | 1.38x | 1.50x |
| Cash Conversion Cycle | 492.95 | 361.25 | 562.84 | 387.61 | 540.42 | 467.93 | 324.13 | 383.1 | 551.04 | 326.9 | 358.49 | 325.91 |
| Total Non-Current Liabilities | 260.41M | 260.26M | 254.85M | 258.82M | 255.51M | 252.23M | 258.41M | 275.53M | 272.71M | 234.19M | 236.88M | 235.46M |
| Long-Term Debt | 31.06M | 31.53M | 31.99M | 218.63M | 217.81M | 217.01M | 216.23M | 230.48M | 229.67M | 190.93M | 190.42M | 188.18M |
| Capital Lease Obligations | 0 | 0 | 0 | 32.44M | 32.87M | 33.26M | 33.64M | 34.02M | 34.4M | 34.76M | 35.15M | 34.87M |
| Deferred Tax Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 3.32M | 2.58M | 2.27M | 2.5M | 2.84M |
| Other Non-Current Liabilities | 229.35M | 228.73M | 222.86M | 7.75M | 4.83M | 1.97M | 8.55M | 7.71M | 6.06M | 6.23M | 8.8M | 9.56M |
| Total Liabilities | 379M | 369.84M | 371.05M | 353.99M | 350.58M | 352.68M | 349.43M | 351.02M | 345.79M | 329.38M | 323.92M | 315.14M |
| Total Debt | 37.33M | 37.76M | 38.19M | 257.22M | 268.75M | 271.45M | 270.96M | 269.8M | 268.69M | 229.19M | 227.94M | 224.99M |
| Net Debt | -74.42M | -73.28M | -53.41M | 197.94M | 210.31M | 199.83M | 211.73M | 212.2M | 206M | 161.74M | 181.8M | 178.82M |
| Debt / Equity | 2.87x | 2.76x | - | - | - | - | - | - | - | - | 58.98x | 16.49x |
| Debt / EBITDA | 3.36x | 1.91x | 3.85x | 33.64x | 5070.77x | 56.41x | - | - | - | - | - | - |
| Net Debt / EBITDA | -6.69x | -3.70x | -5.38x | 25.89x | 3968.13x | 41.53x | - | - | - | - | - | - |
| Interest Coverage | 1.15x | 1.55x | 1.09x | 0.74x | -0.26x | 0.34x | -1.45x | -0.79x | -1.66x | -0.94x | -0.83x | -2.14x |
| Total Equity | 13.01M | 13.69M | -861K | -19.3M | -35.13M | -29.61M | -28.32M | -19.29M | -9.18M | -6.78M | 3.87M | 13.64M |
| Equity Growth % | 137.04% | 146.22% | 96.96% | -0.09% | -282.74% | -336.67% | -832.81% | -241.38% | -130.54% | -115.01% | -92.98% | -81.55% |
| Book Value per Share | 0.07 | 0.08 | -0.00 | -0.12 | -0.23 | -0.20 | -0.19 | -0.13 | -0.07 | -0.05 | 0.03 | 0.10 |
| Total Shareholders' Equity | 13.01M | 13.69M | -861K | -19.3M | -35.13M | -29.61M | -28.32M | -19.29M | -9.18M | -6.78M | 3.87M | 13.64M |
| Common Stock | 18K | 17K | 17K | 16K | 16K | 15K | 15K | 15K | 15K | 14K | 14K | 14K |
| Retained Earnings | -669.07M | -671.31M | -682.39M | -683.01M | -681.08M | -671.86M | -666.75M | -651.01M | -636M | -617.02M | -603.63M | -591.45M |
| Treasury Stock | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accumulated OCI | -24K | -25K | -25K | -24K | -25K | -25K | -16K | -31K | -36K | -25K | -50K | -78K |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |